GRI Bio, Inc. (GRI)
NASDAQ·Healthcare·Biotechnology
$2.10
+2.44%
Mkt Cap $174.27K
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$2.10
+2.44%
Mkt Cap $174.27K
Buy
3
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —